The present invention is directed to methods for alleviating the symptoms
associated with peripheral neuropathy. The neuropathy may be the result of
a genetically inherited condition, systemic disease or exposure to a toxic
agent. A reduction or elimination of symptoms is obtained by administering
the drug selegiline. The invention is also directed to a method for
treating patients with cancer by administering a chemotherapeutic agent
known to have a toxic affect on peripheral nerves together with
selegiline.
